Gabapentin Tablet, Film Coated
Product Images NDC 60687-507

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60687-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

600 mg Blister

600 mg Blister
FDA Label Image

600 mg Carton

600 mg Carton
Gabapentin Tablets, USP are available in a pack of 100 Tablets (10 x 10). It is a prescription-only medicine. The medication needs to be stored at a temperature of 20° to 25°C (88" to 77°F) and should be kept out of reach of children. Patients should not use it if the blister is broken. The drug product in the package belongs to NDC # 68382-204, Zydus Pharmaceuticals (USA) Inc. The tablets should be dispensed along with the medication guide. American Health Packaging distributes this drug, and it has the NDC 60687-507-01.*
FDA Label Image

800 mg Blister

800 mg Blister
Gabapentin is a medication available in tablet form with a dosage strength of 800 mg. The output contains various incomplete and misrecognized texts, but it is clear that it pertains to Gabapentin medication in tablet form.*
FDA Label Image

800 mg Carton

800 mg Carton
NDC 60687-518-01 is a Gabapentin drug tablet provided in containers of 100 tablets (10 x 10) that are only available under prescription (Rx only). Each coated tablet contains Gabapentin, USP. 800mg, with usual dosages explained in detail in the package insert. The tablets have to be stored between 20°C to 25°C (68" to 77°F) with temporary excursions between 15° to 30°C (39" o B6°F). The drug has to be kept safe and unreachable from children. The manufacturer of the drug is Zydus Pharmaceuticals (USA) Inc., which is distributed by American Health Packaging. This text seems to detail the usage instructions and necessary warnings for this particular drug.*
FDA Label Image

Ahp50701

Ahp50701
FDA Label Image

Ahp51801

Ahp51801
FDA Label Image

Equation

Equation
FDA Label Image

Figure 1

Figure 1
The text appears to represent a graph or table showing the Mean Pain Score, a 4-Week Dose Titration Period, and a 4-Week Fixed Dose Period with Placebo and Gabapentin at 3600mg/day. The baseline and week 1 data points are also shown on the graph. It is difficult to provide a useful description without additional context or a visual of the graph.*
FDA Label Image

Figure 2

Figure 2
The text appears to be describing a clinical trial for pain management with a medication called Gabapentin. The trial has two phases: a 3-week dose titration period and a 4-week fixed dose period. The participants are divided into three groups: placebo, Gabapentin 1800mg/day, and Gabapentin 2400mg/day. The graph displays the mean pain score over the 7-week period (baseline, weeks 1-7) for the three groups.*
FDA Label Image

Figure 3

Figure 3
This text appears to be a graph or chart showing percentage values on the y-axis, with a range from 0% to 100%, and some values and a symbol (*) at various points on the x-axis. Additionally, there is some text indicating "Study 2" and some financial values in GBP. The meaning and context of this information is not clear without further information.*
FDA Label Image

Figure 4

Figure 4
FDA Label Image

Structure

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.